301 related articles for article (PubMed ID: 16871759)
1. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
[TBL] [Abstract][Full Text] [Related]
2. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
[TBL] [Abstract][Full Text] [Related]
3. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
[TBL] [Abstract][Full Text] [Related]
5. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Falcão LM; Pinto F; Ravara L; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
7. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
[TBL] [Abstract][Full Text] [Related]
8. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide.
Vinereanu D; Lim PO; Frenneaux MP; Fraser AG
Eur J Heart Fail; 2005 Jun; 7(4):512-9. PubMed ID: 15921788
[TBL] [Abstract][Full Text] [Related]
9. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
[TBL] [Abstract][Full Text] [Related]
10. The utility of NT-proBNP and various echocardiographic methods in the determination of doxorubicin induced subclinical late cardiotoxicity.
Yildirim A; Tunaoglu FS; Kambur K; Pinarli FG
Kardiol Pol; 2013; 71(1):40-6. PubMed ID: 23348532
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
[TBL] [Abstract][Full Text] [Related]
12. Relationship of plasma brain-type natriuretic peptide levels to left ventricular longitudinal function in patients with congestive heart failure assessed by strain Doppler imaging.
Yoneyama A; Koyama J; Tomita T; Kumazaki S; Tsutsui H; Watanabe N; Kinoshita O; Ikeda U
Int J Cardiol; 2008 Oct; 130(1):56-63. PubMed ID: 18068244
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies.
Tragiannidis A; Dokos C; Tsotoulidou V; Giannopoulos A; Pana ZD; Papageorgiou T; Karamouzis M; Athanassiadou F
Minerva Pediatr; 2012 Jun; 64(3):307-12. PubMed ID: 22555323
[TBL] [Abstract][Full Text] [Related]
14. [Early invasive strategy in patients with myocardial infarction and intraventricular conduction disturbances and plasma B-type natriuretic peptide levels assessed 6 months after myocardial infarction].
Ciuraszkiewicz K; Sielski J; Janion-Sadowska A; Sadowski M; Janion M
Pol Merkur Lekarski; 2012 May; 32(191):293-7. PubMed ID: 22779334
[TBL] [Abstract][Full Text] [Related]
15. [Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
Elbl L; Vásová I; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Vorlícek J
Vnitr Lek; 2006 Apr; 52(4):328-38. PubMed ID: 16755989
[TBL] [Abstract][Full Text] [Related]
16. Doppler echocardiography-derived index of myocardial performance (TEI index): comparison with brain natriuretic peptide levels in various heart disease.
Ono M; Tanabe K; Asanuma T; Yoshitomi H; Shimizu H; Ohta Y; Shimada T
Jpn Circ J; 2001 Jul; 65(7):637-42. PubMed ID: 11446498
[TBL] [Abstract][Full Text] [Related]
17. Relation of brain natriuretic peptide to myocardial performance index in adults with congenital heart disease.
Perlowski AA; Aboulhosn J; Castellon Y; Miner P; Child JS
Am J Cardiol; 2007 Jul; 100(1):110-4. PubMed ID: 17599451
[TBL] [Abstract][Full Text] [Related]
18. Correlation between plasma B-type natriuretic peptide levels and left ventricular diastolic function using color kinetic imaging.
Harada M; Hara F; Yamazaki J
J Cardiol; 2010 Jul; 56(1):91-6. PubMed ID: 20447804
[TBL] [Abstract][Full Text] [Related]
19. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
[TBL] [Abstract][Full Text] [Related]
20. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.
Krejci J; Hude P; Poloczkova H; Zampachova V; Stepanova R; Freiberger T; Nemcova E; Spinarova L
Heart Vessels; 2016 Mar; 31(3):416-26. PubMed ID: 25539624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
